← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
Cell-Type-Specific TFEB Modulation Combined with Trehalose f (TFEB) — 0.00 Alpha-theta entrainment therapy to enhance default mode netw (SST) — 0.00 GLUT1-Mediated Carrier-Conjugate Delivery Strategy (LDLR) — 0.00 TBK1 Loss Triggers eIF2α-Mediated Translational Repression T (TBK1, EIF2S1) — 0.00 LDLR-Primed LRP1 Transcytosis with pH-Responsive Escape Stra (LDLR) — 0.00 LAMP2A Upregulation to Enhance Chaperone-Mediated Autophagy (LAMP2A) — 0.00 Closed-loop transcranial focused ultrasound with gamma entra (PVALB) — 0.00 TBK1 Loss Triggers Astrocyte-to-Neuron Senescence Propagatio (TBK1 → NF-κB / IRF3 / p62-autophagy / SASP effectors) — 0.00 Closed-loop transcranial focused ultrasound to restore hippo (SST) — 0.00 LAMP1 Overexpression to Enhance Lysosomal Capacity Independe (LAMP1) — 0.00 eIF2α Phosphorylation Imbalance Disrupts Mitochondrial Prote (EIF2S1,eIF2α,PERK,GCN2,ATF4,TOMM20,TIMM23,NDUFS1,NDUFS3,COX4I1,COX5A,mitochondrial protein import) — 0.00 LDLR-Mediated Neurosteroid Precursor Delivery Strategy (LDLR) — 0.00 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.97 GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl (GRIN2B) — 0.96 Closed-loop optogenetic targeting PV interneurons to restore (PVALB) — 0.96 Closed-loop transcranial focused ultrasound targeting EC-II (SST) — 0.96 Cortico-Striatal Synchrony Restoration via NMDA Modulation (GRIN2B) — 0.95 Gamma entrainment therapy to restore hippocampal-cortical sy (SST) — 0.95 Plasma NfL Elevation Secondary to BBB-Associated Transport D (NEFL) — 0.94 Microglial-Mediated Tau Clearance Dysfunction via TREM2 Rece (MAPT) — 0.94 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming (NLRP3, CASP1, IL1B, PYCARD) — 0.92 Closed-loop transcranial focused ultrasound to restore hippo (CCK) — 0.91 eIF2α Phosphorylation Imbalance Creates Integrated Stress Re (EIF2S1,eIF2α,PERK,GCN2,ATF4,ATF5,CHOP,DDIT3,integrated stress response,protein synthesis) — 0.90 APOE-Dependent Autophagy Restoration (MTOR) — 0.89 Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Colla (SLC16A1, SLC16A7, LDHA, PDHA1) — 0.89 p38α Inhibitor and PRMT1 Activator Combination to Restore Ph (MAPK14/PRMT1) — 0.89 SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senesc (SIRT1) — 0.89 TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegener (TREM2) — 0.89 ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro (ACSL4) — 0.89 Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa (APP/PSEN1 (Aβ production), CHAT (cholinergic synthesis)) — 0.89
Add
|
× TIA1 Low-Complexity Domai
TIA1,TDP-43,TARDBP,G3BP1,MAPK1,Oxidative stress response · als · mechanistic
Composite 0.810
Price $0.70
Evidence For 0
Evidence Against 0
TIA1 (TIA-1) is an essential stress granule (SG) nucleator that undergoes oxidation-sensitive conformational changes in its low-complexity (LC) domain, modulating SG assembly dynamics. This hypothesis proposes that in ALS motor neurons, chronic oxidative stress (elevated ROS, mitochondrial dysfunction) causes irreversible oxidation of TIA1's LC domain cysteines, locking TIA1 into a hyper-assembly state that nucleates aberrant, gel-like SGs with altered material properties. These oxidized TIA1-SG
Radar Chart — 10 Dimensions
Score Breakdown
Dimension TIA1 Low-Complexity Domain Oxi Mechanistic 0.820 Evidence 0.750 Novelty 0.820 Feasibility 0.680 Impact 0.780 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence TIA1 Low-Complexity Domain Oxidation Drives Aberrant Stress No evidence citations yet
Price History Overlay